Publication Category: Medications
Naltrexone/bupropion for obesity
-
Naltrexone/bupropion for obesity Drug Ther Bull
A randomized controlled trial of probiotics to reduce maternal glycaemia in obese pregnancy
- K. Lindsay; O. Maguire; T. Smith; L. Brennan; F. McAuliffe A randomized controlled trial of probiotics to reduce maternal glycaemia in obese pregnancy American journal of obstetrics and gynecology
Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women
-
S. K. Ismail; L. Norris; S. O'Shea; J. R. Higgins
Weight-adjusted LMWH prophylaxis provides more effective thrombin inhibition in morbidly obese pregnant women Thromb Res
Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication
- A. Carballedo; A. Doran; M. Doyle; S. Flavin; J. Tyrrel; F. Kelly; S. Guerin; P. Dodd Assessing metabolic syndrome in people with ID (intellectual disabilities) on antipsychotic medication Ir J Psychol Med
Implication of gut microbiota in the association between infant antibiotic exposure and childhood obesity and adiposity accumulation
-
L. W. Chen; J. Xu; S. E. Soh; I. M. Aris; M. T. Tint; P. D. Gluckman; K. H. Tan; L. P. Shek; Y. S. Chong; F. Yap; K. M. Godfrey; J. A. Gilbert; N. Karnani; Y. S. Lee
Implication of gut microbiota in the association between infant antibiotic exposure and childhood obesity and adiposity accumulation Int J Obes (Lond)
Antibiotic use in early childhood and risk of obesity: longitudinal analysis of a national cohort
-
D. Kelly; A. Kelly; T. O’Dowd; C. B. Hayes
Antibiotic use in early childhood and risk of obesity: longitudinal analysis of a national cohort World Journal of Pediatrics
Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes
- C. Santella; H. Yin; B. M. Hicks; O. H. Y. Yu; N. Bouganim; L. Azoulay Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes Epidemiology
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study
-
M. Movahedi; D. T. Bishop; F. Macrae; J. P. Mecklin; G. Moeslein; S. Olschwang; D. Eccles; D. G. Evans; E. R. Maher; L. Bertario; M. L. Bisgaard; M. G. Dunlop; J. W. Ho; S. V. Hodgson; A. Lindblom; J. Lubinski; P. J. Morrison; V. Murday; R. S. Ramesar; L.
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study J Clin Oncol
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
- R. A. Scott; D. F. Freitag; L. Li; A. Y. Chu; P. Surendran; R. Young; N. Grarup; A. Stancáková; Y. Chen; T. V. Varga; H. Yaghootkar; J. Luan; J. H. Zhao; S. M. Willems; J. Wessel; S. Wang; N. Maruthur; K. Michailidou; A. Pirie; S. J. van der Lee; C. Gills A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease Sci Transl Med